Background: Oxidative stress-induced mitochondrial dysfunction can contribute to inflammation and remodeling in patients with chronic obstructive pulmonary disease (COPD). Mesenchymal stem cells protect against lung damage in animal models of COPD. It is unknown whether these effects occur through attenuating mitochondrial dysfunction in airway cells. Objective: We sought to examine the effect of induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) on oxidative stress-induce mitochondrial dysfunction in human airway smooth muscle cells (ASMCs) in vitro and in mouse lungs in vivo. Methods: ASMCs were cocultured with iPSC-MSCs in the presence of cigarette smoke medium (CSM), and mitochondrial reactive oxygen species (ROS) levels, mitochondrial membrane potential (DCm), and apoptosis were measured. Conditioned medium from iPSC-MSCs and transwell cocultures were used to detect any paracrine effects. The effect of systemic injection of
Chronic obstructive pulmonary disease (COPD) is a progressive airway inflammatory disease characterized by persistent airflow obstruction with poor reversibility usually caused by cigarette smoking. 1 COPD is predicted to become the fourth leading cause of death globally by 2030. 2 The characteristic pathologic features of COPD include a chronic inflammatory response and airway remodeling of the small airways with fibrosis and airway smooth muscle (ASM) thickening, together with emphysema. 3 In addition to their contractile properties, airway smooth muscle cells (ASMCs) have the potential to release proinflammatory mediators and growth factors. [4] [5] [6] Oxidative stress resulting from persistent exposure to reactive oxygen species (ROS) and impaired antioxidant protection is a key player underlying the pathogenesis of COPD. 4 Cigarette smoke (CS) is a major source of ROS, and the effects of oxidative stress can persist even after smoking cessation in patients with COPD, 7 indicating that endogenous ROS resulting from the ensuing inflammatory response might also contribute to the development of oxidative stress.
Mitochondria are a major intracellular source of ROS. 8 Defective oxidative phosphorylation in damaged mitochondria can lead to enhanced mitochondrial ROS production. 8 In addition, loss of mitochondrial membrane potential (DCm) is regarded as an early event in the induction of mitochondrial apoptosis. Recently, mitochondrial dysfunction has been reported in the airways and lungs of patients with COPD [10] [11] [12] [13] and has been shown to contribute to airway inflammation and remodeling in in vivo models of COPD. 10, 14, 15 Defective mitochondrial function, featuring reduced mitochondrial respiration and ATP production, has been reported in ASMCs from patients with COPD. 10 These observations indicate that mitochondria might be a promising therapeutic target for COPD.
Mesenchymal stem cells (MSCs) have shown promise as a potential cell-based therapy for COPD. MSCs display anti-inflammatory effects and attenuate alveolar destruction in animal models of COPD, 16, 17 although the underlying mechanisms remain unresolved. We have reported that the protective effects of induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs), a novel type of MSCs, in a CS-induced rat model of COPD are accompanied by mitochondrial transfer from iPSC-MSCs to airway cells. 18 However, the effect of MSCs on mitochondrial dysfunction remains unknown.
In this study we hypothesized that iPSC-MSCs can attenuate oxidative stress-induced mitochondrial dysfunction in human primary ASMCs and in an oxidant-induced mouse model. [19] [20] [21] [22] The effect of direct coculture with iPSC-MSCs on CS-induced mitochondrial ROS, DCm loss, and induction of apoptosis in ASMCs was investigated. Mitochondrial transfer from iPSC-MSCs to ASMCs was also determined. The paracrine effects of iPSC-MSCs on ASMCs were investigated by using iPSC-MSC conditioned medium (CdM) or a transwell coculture system. Finally, we studied the effect of systemic delivery of iPSC-MSCs on mitochondrial function, airway inflammation, and airway hyperresponsiveness (AHR) in an ozone-induced mouse model.
METHODS
Detailed descriptions of the methods used in this study are listed in the Methods section in this article's Online Repository at www.jacionline.org.
Primary human ASMCs and human iPSC-MSCs
ASMCs were isolated from endobronchial biopsy specimens or tracheas of healthy transplant donor lungs and cultured, as previously described. 23 Human iPSC-MSCs from a single donor were derived by using a previously published protocol. 24 
Direct coculture
Cigarette smoke medium (CSM) was prepared, as previously described. 25 In a prophylactic protocol 1 3 10 5 ASMCs were stained with CellTrace Violet and cultured with 1.5 3 10 5 unstained iPSC-MSCs for 20 hours, followed by CSM (10% or 25%) treatment for 4 hours. Alternatively, in a therapeutic protocol 1 3 10 5 ASMCs were stained with CellTrace Violet and treated with CSM. After 4 hours, CSM was removed, and 1.5 3 10 5 iPSC-MSCs were added to the culture for 24 hours.
Treatment of ASMCs with iPSC-MSC CdM
Supernatants from iPSC-MSC cultures were concentrated 20-fold to create CdM, as previously described. 26 ASMCs were pretreated with 20-fold diluted CdM for 4 hours and then treated with CSM (10% or 25%) for 4 hours.
Transwell coculture
ASMCs (1 3 10 5 ) were grown at the bottom of 6-well culture plates, and 1.5 3 10 5 iPSC-MSCs were grown on cell-culture plate inserts with a pore size of 0.4 mm. Cells were cocultured for 20 hours and then treated with CSM for 4 hours.
Ozone-exposed mouse model
Male C57BL/6 mice were exposed to ozone (3 ppm in air) for 3 hours, as previously reported. [19] [20] [21] [22] iPSC-MSCs (1 3 10 6 ) were intravenously injected 24 hours before or 6 hours after exposure. Twenty-one hours after exposure, AHR was measured, and lungs were collected for analysis.
Isolation of intact mitochondria from mouse lungs
Intact mitochondria were isolated from mouse lungs by using a Mitochondria Isolation Kit for Tissue (Thermo Fisher Scientific, Waltham, Mass), according to the manufacturer's instructions.
Assessment of mitochondrial function and apoptosis
Cells or intact mitochondria were incubated with 5 mmol/L MitoSOX Red, 2 mmol/L 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocyanineiodide (JC-1), or 20-fold diluted fluorescein isothiocyanate (FITC)-conjugated Annexin V to determine changes in mitochondrial ROS, DCm, or apoptosis, respectively. ROS levels in cytoplasmic fractions of mouse lung extracts were determined by using dichlorofluorescein diacetate (10 mmol/L) staining.
Detection of mitochondrial transfer in coculture
CellTrace-labeled ASMCs and MitoTracker-labeled iPSC-MSCs were cultured together for 20 hours and then treated with CSM for 4 hours. The percentage of MitoTracker-positive ASMCs was measured by using fslow cytometry. Alternatively, the cocultured cells were fixed and stained with Alexa Fluor 488-conjugated phalloidin, and mitochondrial transfer was visualized by using fluorescence microscopy. 
F

Detection of apoptosis in mouse lungs
Apoptosis in lung sections was detected by using terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) staining with the In Situ Cell Death Detection Kit (Roche, Mannheim, Germany). Positive cell numbers of 5 random fields for each slide were counted.
Statistical analysis
Data are presented as means 6 SEMs. Statistical analysis was performed with Prism 5.0 software (GraphPad Software, San Diego, Calif). Comparisons in the in vitro study were carried out by using a repeated measures 1-way ANOVA, followed by the Bonferroni post hoc test. In the in vivo study comparisons were carried out with the Kruskal-Wallis test, followed by the Mann-Whitney test for pairwise comparisons. A P value of less than .05 was considered statistically significant.
RESULTS
Effect of direct coculture with iPSC-MSCs on CSM-induced mitochondrial dysfunction and apoptosis in ASMCs
In a prophylactic protocol iPSC-MSCs were directly cocultured with CellTrace-labeled ASMCs for 20 hours and then treated with CSM (10% and 25%) for 4 hours. ASMCs were identified as CellTrace-positive and iPSC-MSCs as CellTrace-negative cells by using flow cytometry (Fig 1, A) .
Mitochondrial ROS levels were measured in the gated ASMC (CellTrace-positive) population and compared with ASMCs in the single culture. CSM increased the levels of mitochondrial ROS in ASMCs in single culture in a concentration-dependent manner (Fig 1, B) , an effect partially prevented by coculture with iPSC-MSCs (Fig 1, B) . In the therapeutic protocol CellTrace-labeled ASMCs were treated with CSM for 4 hours before iPSC-MSCs were added to the culture and incubated for a further 20 hours. Under these conditions, only 25% CSM led to a significant increase in mitochondrial ROS (Fig 1, C) . A small but significant reduction in mitochondrial ROS was observed in ASMCs of the coculture group compared with the single culture treated with 25% CSM (Fig 1, C) .
In the prophylactic experiment CSM induced a concentrationdependent reduction in DCm in single cultures of ASMCs (Fig 1,  D) . Coculture with iPSC-MSCs prevented the reduction in DCm induced by both 10% and 25% CSM treatment (Fig 1, D) . In the therapeutic experiment 20 hours after removal of CSM, single cultures of ASMCs continued to show significantly reduced DCm in both the 10% and 25% CSM-treated group (Fig 1, E) . In contrast, CSM did not significantly reduce DCm in ASMCs cocultured with iPSC-MSCs (Fig 1, E) .
Observing that iPSC-MSCs were more effective in attenuating CSM-induced mitochondrial dysfunction under the prophylactic protocol, we used this protocol to study the effect of coculture on ASMC apoptosis. CSM increased the percentage of single-cultured ASMCs at 25% and 50% CSM (Fig 1, F) . In the absence of stimulation, iPSC-MSCs increased significantly the percentage of apoptotic ASMCs compared with those in the single culture (Fig 1, F) . However, iPSC-MSCs led to a significant reduction in apoptosis induced by 25% and 50% CSM, indicating that direct interaction with iPSC-MSCs can protect ASMCs from CSM-induced apoptosis (Fig 1, F) .
Paracrine effects of iPSC-MSCs on CSM-induced mitochondrial dysfunction and apoptosis in ASMCs
We studied the contribution of paracrine mediators to the protective effects of iPSC-MSCs on CSM-induced ASMC mitochondrial dysfunction and apoptosis by treating ASMCs with CdM from iPSC-MSCs or using transwell cocultures. ASMCs treated with CdM demonstrated significantly lower levels of mitochondrial ROS in response to both 10% and 25% CSM (Fig 2, A) compared with ASMCs cultured without CdM. However, CdM had no significant effect on CSM-mediated reduction in DCm (Fig 2, B) or induction of apoptosis (Fig 2, C) .
In line with the findings from CdM experiments, ASMCs in transwell coculture with iPSC-MSCs demonstrated significantly lower levels of mitochondrial ROS induced by 25% CSM compared with ASMCs (Fig 3, A) compared with those cultured with blank inserts. However, no significant difference in DCm (Fig 3, B) and apoptosis (Fig 3, C) was observed between the iPSC-MSC treatment and blank insert.
Mitochondrial transfer from iPSC-MSCs to ASMCs
To investigate mitochondrial transfer from iPSC-MSCs to ASMCs, ASMCs were prestained with CellTrace Violet, whereas iPSC-MSCs were prestained with the mitochondrialtargeted dye MitoTracker Red. Cells were cocultured for 20 hours, followed by 4 hours of stimulation with 25% CSM, and further stained with phalloidin which selectively stains F-actin fibers. MitoTracker-labeled mitochondria were observed in CellTrace-labeled ASMCs, indicating transfer of mitochondria from iPSC-MSCs to ASMCs (Fig 4, A) . Tunneling nanotube (TNT)-like structures, containing iPSC-MSC mitochondria were observed connecting iPSC-MSCs and ASMCs. Actin filaments were identified in the TNTs, confirming a connection between the cytoskeletons of the 2 cell types (Fig 4, A) .
The percentage of MitoTracker-positive cells in the ASMC population was quantified by using flow cytometry (Fig 4, B) . CSM increased the mitochondrial transfer rate in a concentration-dependent manner (Fig 4, C) . Under similar experimental conditions, green fluorescence protein-tagged mitochondria from iPSC-MSCs were observed in TNT-like structures between iPSC-MSCs and ASMCs and, importantly, also in CellTrace-labeled ASMCs (see Fig E1 in 
Effect of iPSC-MSCs on ozone-induced cellular ROS, mitochondrial dysfunction, and apoptosis in mouse lungs
The effects of iPSC-MSCs on mitochondrial function and apoptosis were studied in mice acutely exposed to ozone. There were 5 treatment groups in this study: air/saline (n 5 5), air with iPSC-MSCs administrated 24 hours before exposure (air/224h; n 5 5), ozone/saline (n 5 6), ozone with iPSC-MSCs administrated 24 hours before exposure (ozone/224h; n 5 6), and ozone with iPSC-MSCs administrated 6 hours after exposure (ozone/16h; n 5 6). Ozone exposure significantly increased cytoplasmic ROS levels. No significant effects were observed in either the ozone/224hr or ozone/16hr group in comparison with the ozone/saline group (Fig 5, A) .
Mitochondrial ROS levels were significantly increased in the ozone/saline group compared with the air/saline group (Fig 5, B) . Both the ozone/224hr and the ozone/16hr groups demonstrated significantly reduced mitochondrial ROS levels compared with the ozone/saline group. In addition, mitochondrial ROS levels in the ozone/16hr group were significantly lower than those in the ozone/224hr group (Fig 5, B) .
Exposure to ozone reduced the DCm of isolated mitochondria in comparison with that in the air/saline group (Fig 5, C) . The ozone/224hr group showed an increase in DCm compared with the ozone/saline group. However, the ozone/16hr group did not show a significant difference compared with the ozone/saline group, and the DCm was still significantly lower than that of the air/saline group.
Ozone exposure significantly increased the number of apoptotic cells in lung sections in the saline groups (Fig 6) . Both the ozone/224hr and ozone/16hr groups showed a significantly reduced number of apoptotic cells compared with the ozone/saline group (Fig 6) .
Effect of iPSC-MSCs on ozone-induced AHR and lung inflammation
Pulmonary resistance (R L ) in response to increasing concentrations of acetylcholine was measured 21 hours after exposure (Fig 7, A) . The ozone/saline group demonstrated significantly increased AHR compared with the air/saline group, as shown by a reduction in the concentration of acetylcholine that increased lung resistance by 100% (Fig 7, B) . The ozone/224hr group showed significantly lower AHR compared with that in the ozone/saline group (Fig 7, B) . The ozone/16hr group, in contrast, did not exhibit a difference in AHR compared with that in the ozone/saline group (Fig 7, B) .
The ozone/saline group demonstrated significantly higher total cell numbers in BAL fluid compared with those in the air/saline group (Fig 7, C) , with increased numbers of neutrophils (Fig 7, D) , macrophages (Fig 7, E) , eosinophils (Fig 7, F) , and lymphocytes (Fig 7, G) . Total cell numbers in the ozone/224hr group were significantly lower compared with those in the ozone/saline group, whereas the ozone/16hr group did not show any effect (Fig 7, C) . The ozone/224hr group showed significantly reduced neutrophil numbers compared with the ozone/saline group (Fig 7, D) , whereas the ozone/16hr group did not show any effect. Macrophage, eosinophil and lymphocyte numbers showed a decreasing trend in the ozone/224hr and/or the ozone/16hr group, which did not reach statistical significance (Fig 7, E-G) .
Thus iPSC-MSCs were able to prevent but not reverse ozone-induced AHR and recruitment of inflammatory cells into the lung.
DISCUSSION
We have shown that direct coculture of ASMCs with iPSC-MSCs protected the former from CSM-induced mitochondrial ROS production, mitochondrial depolarization, and , and DCm (C) in the lungs of mice exposed to ozone (3 ppm) for 3 hours. *P < .05 and **P < .01 compared with air/saline; #P < .05 compared with air/224hr; P < .05 and P < .01 compared with ozone/saline; and § §P < .01 compared with ozone/224hr. Means 6 SEMs are shown. apoptosis. When ASMCs were exposed to supernatants from iPSC-MSCs or transwell inserts with iPSC-MSCs, only CSM-induced mitochondrial ROS, but not mitochondrial depolarization and apoptosis in ASMCs, were ameliorated, indicating that soluble factors from iPSC-MSCs reduced production of mitochondrial ROS. When there was direct contact between iPSC-MSCs and ASMCs, mitochondria were transferred from iPSC-MSCs to ASMCs, possibly through formation of TNTs, an effect that was enhanced by CSM treatment. iPSC-MSCs were also able to prevent, but not reverse, ozone-induced mitochondrial dysfunction, AHR, and airway inflammation in a mouse model, an effect likely to be a result of direct interaction and mitochondrial transfer between iPSC-MSCs and airway cells. MSCs are fibroblast-like multipotent stem cells residing in various tissues, such as bone marrow and adipose tissue. 27 The in vitro differentiation of iPSCs into iPSC-MSCs provides a new source of MSCs. Compared with bone marrow mesenchymal stem cells (BM-MSCs), iPSC-MSCs were shown to have a higher proliferative and differentiation potential 24 and a superior capacity to attenuate CS-induced airway inflammation, apoptosis, and emphysema in rats. 18, 28 Here, for the first time, we demonstrate that iPSC-MSCs are capable of alleviating oxidative stress-induced mitochondrial dysfunction in lung cells. The therapeutic effects of iPSC-MSCs appear to be less pronounced than the prophylactic effects both in vitro and in vivo, possibly because of the progression of mitochondrial dysfunction to an irreversible stage, the partial recovery of mitochondrial function after removal of CSM stimulation in vitro, or shorter length of treatment time of iPSC-MSCs in vivo.
Targeting mitochondrial dysfunction represents a novel strategy for developing treatments for COPD. Mitochondrial dysfunction has been demonstrated in ASMCs from patients with COPD, as characterized by a reduction in ATP levels, mitochondrial complex protein expression, and membrane potential, as well as an increase in mitochondrial ROS. 10 The mitochondrial-targeted antioxidant MitoQ was found to prevent both mitochondrial dysfunction and airway inflammation and AHR in an ozone-induced mouse model, indicating that mitochondrial dysfunction can contribute to the development of disease pathology. 10 CSM was reported to induce mitochondrial dysfunction, involving increased mitochondrial fragmentation and ROS production and a reduction in mitochondrial respiration in airway epithelial cells 11 and ASMCs. 29 Oxidative stress-induced mitochondrial dysfunction can further induce oxidative stress, leading to apoptosis, 8, 9 which contributes to the alveolar destruction seen in patients with COPD. 30 In the current study we demonstrated that alleviation of oxidative stress-induced mitochondrial dysfunction by iPSC-MSCs was accompanied by reduced apoptosis and airway inflammation and AHR in mice.
Although MSCs have been reported to induce paracrine effects by releasing immune-regulatory cytokines, 16 in the present study CdM was only able to ameliorate CSM-induced mitochondrial ROS in ASMCs without any effect on DCm or apoptosis. It is possible that the release of protective paracrine factors by iPSC-MSCs might be triggered by mediators produced by the damaged ASMCs. However, in a transwell coculture system in which there is paracrine crosstalk between the 2 cell types, iPSC-MSCs also prevented CSM-induced mitochondrial ROS production but not reduction of DCm or apoptosis in ASMCs. Therefore paracrine factors might only contribute in part to the protective effects of iPSC-MSCs, and direct cell-cell contact is crucial for the full protective effects to take place.
Mitochondrial transfer was first identified in cocultures of BM-MSCs and lung epithelial cells with defective mitochondria. 31 Mitochondrial transfer from MSCs to epithelial cells was also observed in vivo in rodent models of acute lung injury 32 and CS-induced emphysema. 18 In the current study we report mitochondrial transfer from iPSC-MSCs to ASMCs, which is enhanced by CSM. A previous study reported that CS exposure can lead to a reduction in the supply of respiratory substrates to the electron transport chain in mouse lungs, leading to increased bioenergetic demand. 15 Transfer of iPSC-MSC-derived mitochondria might enhance the bioenergetic capacity of ASMCs and thus prevent CSM-induced mitochondrial stress. In addition, mitochondrial transfer can exert its effects indirectly by activating protective signaling pathways involved in the activation of antioxidant responses and/or mitochondrial biogenesis and quality control. Understanding these mechanisms will require further investigation.
We observed formation of TNTs connecting the cytoskeletons of iPSC-MSCs and ASMCs. TNTs are highly sensitive nanotubular structures that facilitate the selective transfer of membrane-bound vesicles and organelles between cells.
33 TNTs have been reported to mediate mitochondrial transfer from BM-MSCs to epithelial cells, from endothelial cells to cancer cells, and from vascular smooth muscle cells to MSCs.
31,34,35
Therefore mitochondrial transfer from iPSC-MSCs to ASMCs can occur through TNTs. Recent studies have demonstrated that the mitochondrial Rho-GTPase Miro1 facilitates mitochondrial movement through the TNTs.
36,37 The mechanisms driving TNT formation, mitochondrial movement, or both between iPSC-MSCs and ASMCs in response to oxidative stress will be investigated in the future.
Despite the reduction in ozone-induced mitochondrial ROS by iPSC-MSCs, ozone-induced cytoplasmic ROS levels were not modulated by iPSC-MSCs. These results suggest that instead of a general antioxidant effect, the protective action of iPSC-MSCs might be through specifically restoring mitochondrial dysfunction. This might explain why antioxidants, such as N-acetylcysteine, that do not target mitochondria have not had much clinical success in the treatment of COPD.
38
There are several limitations to this study. First, in the absence of CSM treatment, coculture with iPSC-MSCs increased apoptosis of ASMCs, suggesting that iPSC-MSCs can induce stress in the target cells at baseline. Such data imply that the safety of iPSCMSCs should be carefully examined. Moreover, although we used in vitro and in vivo models of oxidative stress-induced mitochondrial dysfunction, these do not represent the situation in lungs of patients with COPD. Therapeutic potential of iPSC-MSCs in patients with COPD can be confirmed further by studying ASMCs from patients with COPD, in which mitochondria are known to be already impaired. 10 We have chosen to study the effect of iPSC-MSCs on ASMCs because these cells were shown to have impaired mitochondrial function in patients with COPD 10 and are known to play a key role in the development of airway remodeling and inflammation. 4, 39 However, it would be crucial to determine the efficacy of iPSC-MSCs on other airway cell types, such as epithelial cells and fibroblasts, to gain a better understanding of the potential of iPSC-MSCs as cell-based therapy for lung disease.
Second, an additional limitation could include our use of CSM prepared by using Marlboro Red cigarettes instead of research cigarettes, which are produced to provide standardized amounts of components in the CS. However, although we used commercial cigarettes, the effects of CSM on mitochondrial function and apoptosis were very consistent between experiments despite using primary cells that have an inherent variability in their responses. To minimize further the variability in the CSM preparations, we used a peristaltic pump to bubble the CS into the medium at a constant speed.
Third, TNTs are not only involved in mitochondrial transfer but might also facilitate the exchange of other cellular organelles or molecules that can protect the ASMCs from mitochondrial dysfunction.
Finally, a drawback of using fluorescent dyes to study mitochondrial transfer is that any dye leaking out from dead iPSC-MSCs can be taken up by ASMCs, leading to false-positive results. We have addressed this by expressing fluorescencelabeled mitochondria in iPSC-MSCs. These data confirm mitochondrial transfer through TNTs from iPSC-MSC to ASMC in response to stimulation with CSM.
In summary, we have shown that the capacity of iPSC-MSCs to attenuate oxidative stress-induced mitochondrial dysfunction and to protect against lung damage and inflammation relies on direct cell-cell contact that allows mitochondrial transfer. We conclude that iPSC-MSCs are effective in protecting against oxidative stress-induced mitochondrial dysfunction in the lungs and are thus a promising candidate for development of cell-based therapies in patients with COPD.
We thank Dr Han Shuo and Dr Liang Yingmin for their contribution to performing the studies described in the Methods section in this article's Online Repository.
Key messages
d iPSC-MSCs protect against CSM-induced mitochondrial dysfunction and apoptosis in ASMCs.
d The protective effect of iPSC-MSCs against CSM-induced mitochondrial dysfunction can be exerted through mitochondrial transfer and paracrine effects. iPSCMSCs prevent mitochondrial dysfunction, AHR, and inflammation in an ozone-induced mouse model of COPD, highlighting the potential of these cells as a novel cell-based therapy. 
METHODS
Primary human ASMCs
ASMCs were isolated from biopsy specimens of bronchi or tracheas of healthy transplant donor lungs, as previously described. E1 Briefly, endobronchial biopsy specimens were cut into small pieces (<1 mm 2 ) and placed in Dulbecco modified Eagle medium (DMEM) supplemented with 10% FBS, 4 mmol/L L-glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, 2.5 mg/mL amphotericin B, and 10% FBS at 378C in a 5% CO 2 and humidified atmosphere to allow attachment and growth of ASMCs. Alternatively, ASMCs were dissected from tracheal segments from healthy transplant donor lungs.
ASMCs were identified by the characteristic ''hill and valley'' morphology under light microscopy. Cell stocks were kept in 175-cm 2 flasks at 378C in a 5% CO 2 and humidified atmosphere. Experiments were carried out on cells at passages 3 to 7. Cells were treated in serum-free medium, which consisted of phenol red-free DMEM supplemented with 1 mmol/L sodium pyruvate, 4 mmol/L L-glutamine, 1:100 nonessential amino acids, 0.1% BSA, 100 U/mL penicillin, 100 mg/mL streptomycin, and 2.5 mg/mL amphotericin B.
Human iPSC-MSCs
Human iPSC-MSCs were derived based on a previously published protocol. E2 Briefly, IMR90 fibroblast cells (catalog no. CCL-186; American Type Culture Collection, Manassas, Va) were transduced with lentiviral vectors carrying human OCT4, SOX2, NANOG, and LIN28 genes (Plasmid 16577-80; Addgene, Cambridge, Mass), followed by incubation with ES culture medium on inactivated mouse embryonic fibroblast feeder for 20 days. Colonies with human embryonic stem cell morphology were identified as iPSCs. For induced differentiation, iPSCs were incubated in DMEM (Gibco, Carlsbad, Calif) supplemented with 10% serum replacement medium (Gibco), 10 ng/mL basic fibroblast growth factor (Gibco), 10 ng/mL platelet-derived growth factor AB (PeproTech, Rocky Hill, NJ), and 10 ng/mL epidermal growth factor (PeproTech). One week later, differentiating iPSCs were harvested, incubated with CD24-phycoerythrin and CD105-FITC (BD PharMingen, San Diego, Calif), and sorted by using fluorescence-activated cell sorting. CD24
2 CD105 1 cells were subcultured in 96-well culture plates to select wells containing a single cell. The clones from a single cell were serially reseeded to obtain a confluent 175-cm 2 tissue culture flask. The iPSC-MSCs were examined for surface marker profile (CD44 1 , CD49a
2 , and CD133 2 ). In addition, differentiation capacity was tested by using efficient adipogenesis, osteogenesis, and chondrogenesis. They were then frozen for future experiments. The iPSC-MSCs were cultured in DMEM (Gibco) supplemented with 10% FBS (Gibco), basic fibroblast growth factor (5 ng/mL), and epidermal growth factor (10 ng/mL). Cells were maintained in a humidified 378C incubator with 5% CO 2 .
CSM CSM was prepared, as previously described. E3 Briefly, CS from 2 filter-removed Marlboro Red cigarettes (10 mg of tar and 0.8 mg of nicotine) was bubbled into 20 mL of serum-free medium by using a peristaltic pump. The medium was then filtered through a 0.22-mm filter. The OD of the solution at a wavelength of 320 nm was measured. One hundred percent CSM solution was generated by adjusting the OD of the solution to 1.1 absorbance units by diluting in serum-free medium.
We are aware of the importance of consistency and reproducibility for CS-related studies because of the complex chemical components in CS. To this end, we have put effort into optimizing our preparation protocol to produce consistent and reproducible CSM. Specifically, we used a peristaltic pump instead of a syringe to bubble the CS into medium, as used in many previous reports that used both commercial cigarettes E4-E7 and research cigarettes E8 because we found that application of a constant pumping speed significantly reduces the variability of the CSM extracts. The OD at 320 nm was used as the indication CSM concentration (OD 320 5 1.1 was defined as 100%). We also found that only small variabilities between preparations should be adjusted by means of dilution (eg, OD 320 5 1.2 or 1.3, adjusted to 1.1 by dilution and considered 100%). We discarded the CSM preparations if OD 320 was greater than 1.5 and prepared a new batch with OD 320 close to 1.1. The resulting CSM preparations showed consistent effects on mitochondrial function and apoptosis in our experiments.
Direct coculture of ASMCs and iPSC-MSCs
Direct coculture of ASMCs and iPSC-MSCs was carried out with a prophylactic or a therapeutic protocol.
For the prophylactic protocol, ASMCs were trypsinized, pelleted, resuspended, and counted. ASMCs (1 3 10 6 ) were washed with HBSS and then incubated with CellTrace Violet solution (Invitrogen, Paisley, United Kingdom) and diluted 1:1000 in HBSS for 20 minutes. After centrifugation, ASMCs were incubated with complete medium for 10 minutes to wash and neutralize the dye. CellTrace-labeled ASMCs were mixed with the unstained iPSC-MSCs and seeded in 6-well culture plates at densities of 1 3 10 5 ASMCs and 1.5 3 10 5 iPSC-MSCs per well. Wells containing only 1 3 10 5 ASMCs were used as controls (single-culture control). After 20 hours, the medium was replaced with CSM (10% to 50%) for 4 hours before the cells were harvested for analysis.
For the therapeutic protocol, 1 3 10 5 ASMCs were seeded in 6-well culture plates at a density of 1 3 10 5 cells/well and allowed to attach for 20 hours. ASMCs were then incubated with CellTrace Violet solution (1:1000 in HBSS) for 20 minutes, followed by treatment with CSM (10% to 25%) for 4 hours. The CSM-containing medium was then removed, and 1.5 3 10 5 iPSC-MSCs were added to each well for a further 24 hours before the cells were harvested for analysis.
Transwell coculture of ASMCs and iPSC-MSCs
ASMCs were seeded in 6-well plates at a density of 1 3 10 5 /well. iPSC-MSCs were seeded in a cell-culture insert with 0.4-mm pores (Falcon; Corning, Corning, NY) at a density of 1.5 3 10 5 /well. ASMCs and iPSCMSCs were incubated separately for 20 hours to allow attachment overnight, and then the inserts were transferred into 6-well plates containing the ASMCs. ASMCs cultured in the presence of empty inserts were used as controls. After 20 hours of coculture, cells were treated with CSM (10% to 25%) for 4 hours, and ASMCs were harvested for analysis.
Treatment of ASMCs with iPSC-MSC CdM
iPSC-MSC CdM was prepared, as previously described. E9 Briefly, iPSC-MSCs were cultured in serum-and supplement-free DMEM for 24 hours. The supernatant was collected and concentrated 20-fold through centrifugation in ultrafiltration conical tubes (Amicon Ultra-15 with 5-kDa cutoff membranes). ASMCs were pretreated with 20-fold diluted CdM for 4 hours. CSM was then added to the CdM at a final concentration of 10% or 25% and incubated for 4 hours before ASMCs were harvested for analysis. ASMCs in the control group were incubated with non-CdM.
Detection of mitochondrial transfer in coculture
To detect mitochondrial transfer in cocultures of ASMCs and iPSC-MSCs, ASMCs were prestained with CellTrace Violet (Invitrogen), and iPSC-MSCs were prestained with MitoTracker Red (Invitrogen) for fluorescent microscopy or MitoTracker Green (Invitrogen) for flow cytometry, according to the manufacturer's instructions. Cells were mixed and seeded in 6-well plates at a density of 1 3 10 5 ASMCs and 1.5 3 10 5 iPSC-MSCs per well. Twenty hours later, cells were treated with CSM (10% to 50%) and analyzed by means of flow cytometry. The percentage of MitoTracker-positive ASMCs was subsequently determined. For fluorescent microscopy, cells were fixed with 3.7% formaldehyde (Sigma-Aldrich, Dorset, United Kingdom) for 10 minutes, permeabilized in 0.1% Triton X-100 (Sigma-Aldrich) for 5 minutes, and stained with Alexa Fluor 488-conjugated phalloidin (Invitrogen) in PBS with 1% BSA. Cells were then visualized with an inverted fluorescence microscope.
Mitochondrial ROS
Changes in mitochondrial ROS levels were assessed by staining with MitoSOX Red Mitochondrial Superoxide Indicator (Invitrogen). In the in vitro study cells in 6-well plates were washed with modified HBSS (containing Ca/Mg; Sigma-Aldrich) and incubated with 5 mmol/L MitoSOX diluted in modified HBSS for 30 minutes. Cells were then washed with HBSS without Ca/Mg (Sigma-Aldrich) and detached by means of incubation with Accutase (Sigma-Aldrich) for up to 5 minutes at 378C in a 5% CO 2 atmosphere. Cells were pelleted and resuspended in HBSS, and the median intensity of red fluorescence was determined with a FACSCanto II flow cytometer (BD Biosciences). For the in vivo study, intact mitochondria isolated from mouse lungs were incubated with 5 mmol/L MitoSOX in 96-well plates for 30 minutes at 378C. Fluorescence was measured at 510/580 nm by using a fluorescence plate reader.
DCm
Changes in DCm were determined by staining with JC-1 dye (Invitrogen). ASMCs or intact mitochondria from mouse lungs were incubated with 2 mmol/L JC-1 for 30 minutes at 378C. The fluorescent signal was determined either by using a FACSCanto II flow cytometer (BD Biosciences) for cells or a fluorescence plate reader (Synergy HT; BioTek, Winooski, Vt) for isolated mouse mitochondria. Green fluorescence was measured at excitation/emission ratios of 485/535 nm, and red fluorescence was measured at 560/595 nm, and the ratio of red/green fluorescence was determined.
Annexin V staining
Apoptosis in cultured cells was detected by using Annexin V staining. Briefly, cells were harvested, resuspended at a density of 1 3 10 6 cells/mL in assay buffer, incubated with 20-fold-diluted FITC-conjugated Annexin V solution (Invitrogen) for 15 minutes, and analyzed by using flow cytometry.
Ozone-exposed mouse model
Experiments were performed under a Project License from the British Home Office, United Kingdom, under the Animals (Scientific Procedures) Act of 1986. Male C57BL/6 mice were exposed to ozone at a concentration of 3 ppm for 3 hours by using an ozonizer (model 500 Ozoniser; Sander, Wuppertal, Germany). Control mice were exposed to ambient air. iPSC-MSCs (1 3 10 6 ) or PBS were administrated to mice by means of intravenous injection through the tail vein. Administration was performed either 24 hours before (prophylactic protocol) or 6 hours after (therapeutic protocol) exposure. The treatment groups were as follows: air/saline, air with iPSC-MSCs administrated 24 hours before exposure (Air/224hr), ozone/ saline, ozone with iPSC-MSCs administrated 24 hours before exposure (ozone/224hr), and ozone with iPSC-MSCs administrated 6 hours after exposure (ozone/16hr).
Mice were anesthetized for AHR measurements 21 hours after exposure and killed immediately after AHR measurements by means of intraperitoneal injection of overdosed pentobarbitone (100 mg/kg body weight). BAL fluid was collected before lung collection. Right lobes were frozen for mitochondrial extraction, and left lobes were inflated with and fixed in paraformaldehyde. The larger lobes of the fixed lungs were later embedded into paraffin blocks and sectioned into 5-mm sections.
AHR in mice
AHR was measured, as previously described. E10 Mice were anesthetized by means of intraperitoneal injection of ketamine/xylazine/saline mixture. The trachea was opened and inserted with a catheter through which the mouse was ventilated (MiniVent type 845; Hugo Sachs Elektronik, March, Germany) at 250 breaths/min and a tidal volume of 250 mL. The animal was continuously monitored in a whole-body plethysmograph (EMMS, Hants, United Kingdom). R L was recorded for 3-minute periods during administration of increasing concentrations (4-256 mg/mL) of acetylcholine in PBS. Baseline R L was defined as the R L with nebulized PBS. A concentration-response curve was plotted for each animal, and the concentration of acetylcholine that induced a 100% increase in R L from baseline was derived (PC 100 ). The concentration of acetylcholine that increased lung resistance by 100% was taken as a measurement of AHR.
Measurement of cells and cytokines in BAL fluid of mice
BAL fluid was collected by rinsing the lungs 3 times with 0.8 mL of PBS through an endotracheal tube. After centrifugation at 3000 rpm an 48C for 5 minutes, the supernatant was collected as BAL fluid, whereas cell pellets were resuspended in 200 mL of PBS and counted on a hemocytometer for total cell numbers. BAL fluid cell samples were centrifuged onto glass slides at 30g for 6 minutes (Shandon Cytospin 4; Thermo Electron, Waltham, Mass). The resulting cell slides were air-dried overnight and stained with the Diff-Quick Kit (Reagena, Toivala, Finland), according to the manufacturer's instructions. Differential counts of white blood cells (neutrophils, macrophages, lymphocytes, and eosinophils) were performed with an optical microscope (Olympus BH2; Olympus, Center Valley, Pa).
Isolation of intact mitochondria from mouse lungs
Intact mitochondria were isolated from mouse lungs by using a Mitochondria Isolation Kit for Tissue (Thermo Fisher Scientific) and a Dounce tissue grinder set (Sigma), according to the manufacturer's instructions. In brief, approximately 20 mg of lung tissue was washed with PBS supplemented with EDTA-free protease inhibitors (Roche). The tissue was homogenized with 5 strokes of Douncer A, followed by 20 strokes of Douncer B, in the corresponding reagent. The homogenates were centrifuged first at 700g for 10 minutes at 48C to sediment large organelle fractions. The supernatants were centrifuged at 12,000g for 5 minutes. The supernatants and pellets were collected as cytosolic fractions and mitochondrial fractions, respectively.
Detection of apoptosis in mouse lungs
Apoptosis in mouse lung sections was determined by using the TUNEL assay with the In Situ Cell Death Detection Kit, POD (Roche Applied Science, Mannheim, Germany). Lung sections were serially rehydrated and antigen retrieved in sodium citrate buffer (10 mmol/L sodium citrate and 0.05% Tween 20, pH 6.0) by heating in a microwave oven for 5 minutes. They were then washed with PBS and incubated with TUNEL reaction mixture for 1 hour. Lung sections were then washed and mounted in mounting medium (ProLong Gold antifade reagent with DAPI, Invitrogen) containing 49-6-diamidino-2-phenylindol dihydrochloride. Images of 5 random fields for each slide were captured at 320 magnification by using a motorized inverted microscope (Olympus) and analyzed with AxioVision (Zeiss, Oberkochen, Germany).
FIG E1.
Detection of mitochondrial transfer from Mito-GFP-iPSC-MSCs to ASMCs. iPSC-MSCs were transfected with mitochondrial-targeting green fluorescence protein (mito-GFP; pCT-MITO-GFP, catalog no. Cyto102-PA-1, System Biosciences, Palo Alto, Calif) by using lentiviral-mediated transfection, as previously described, E11 to avoid leakage of MitoTracker from iPSC-MSCs to contaminate ASMCs. Subsequently, CellTrace-labeled ASMCs and Mito-GFP-iPSC-MSCs were cocultured for 20 hours and then treated with CSM (10% or 25%) for 4 hours, respectively. After treatment, cocultured cells were stained with Fulor-594-conjugated phalloidin, and then mitochondrial transfer from Mito-GFP-iPSCMSCs to ASMCs was examined by using fluorescence microscopy. Furthermore, the percentage of Mito-GFP-positive ASMCs was evaluated by using fluorescence-activated cell sorting (FACS). Sorted Mito-GFP 1 and Mito-GFP 2 AMSCs were further examined by using fluorescent microscopy to confirm the Mito-GFP-mitochondria in the cells. Mito-GFP-iPSC-MSCs were cocultured with CellTrace-labeled ASMCs for 20 hours and then exposed to CSM (10%, 25%) challenge. After 4 hours of treatment, phalloidin staining showed that TNTs were formed between iPSC-MSCs and ASMCs, allowing mitochondrial transfer from MSCs to ASMCs (Fig E1, A) . Importantly, some Mito-GFP mitochondria were observed in the middle of the TNTs (Fig E1, A) . Mitochondrial transfer from Mito-iPSC-MSCs to ASMCs was also detected by using FACS (Fig E1, B) . Data show some CellTrace-labeled ASMCs were also positive for GFP, suggesting that mitochondria were transferred from MSCs to ASMCs (Fig E1, B) . Moreover, compared with 10% CSM stimulation, more effective mitochondrial transfer from Mito-GFP-iPSC-MSCs to ASMCs was detected after 25% CSM stimulation (P < .01; Fig E1, D) . Finally, Mito-GFP 1 ASMCs and Mito-GFP 2 ASMCs were isolated and then stained with phalloidin to verify the successful mitochondrial transfer. Fluorescent microscopy showed that Mito-GFP mitochondria was only observed in Mito-GFP 1 ASMCs but not Mito-GFP 2 ASMCs (Fig E1, C) . To address this specific concern, we performed a transwell culture experiment to test the possibility that MitoTracker released from dead or dying iPSC-MSCs can be taken up by ASMCs under our experimental conditions, leading to false-positive results. Specifically, ASMCs prestained with CellTrace were seeded in 6-well plates. Transwell inserts (pore size, 0.4 mm) containing MitoTracker-labeled iPSC-MSCs or no cells were put into the 6-well plates for 20 hours, followed by a 4-hour treatment with CSM. Results showed there was no detectable uptake of MitoTracker dye by possible release from iPSC-MSCs. Importantly, these data show that the increase in MitoTracker staining in ASMCs under our coculture conditions is as a result of active mitochondrial transfer, which is unlikely to be influenced by leakage of dye from iPSC-MSCs. CellTrace-labeled ASMCs were seeded in wells of 6-well tissue culture plates, and MitoTrackerlabeled iPSC-MSCs were seeded in inserts. ASMCs and iPSC-MSCs were cocultured for 20 hours and then incubated with CSM (10% or 25%) for 4 hrs. ASMCs cultured with blank inserts and treated with CSM (10% or 25%) were used as controls. MitoTracker staining in ASMCs (CellTrace positive) was detected by using flow cytometry.
